维普中文期刊产品整合服务
839篇 您的检索式:作者名="Moral L"
    题名 作者 年代 出处 被引量
1Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotectionJrepair in Parkinson's disease显示文摘Francesca L'Episcopo Cataldo Tirolo Salvo Caniglia Nuccio Testa Maria Concetta Moral~ Maria Francesca Serapide: Stefano Pluchino Bianca Marchetti 2014Journal of Molecular Cell Biology2014,8,1:8
2ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS显示文摘AIM:To investigate the interstitial cells of Cajal(ICC) number using a new rat model.METHODS:Sprague-Dawley rats were assigned to two groups.The first group received gavage with Campylobacter jejuni(C.jejuni) 81-176.The second group was gavaged with placebo.Three months after clearance of Campylobacter from the stool,precise segments of duodenum,jejunum,and ileum were ligated in self-contained loops of bowel that were preserved in anaerobic bags.Deep muscular plexus ICC(DMP-ICC) were quantified by two blinded readers assessing the tissue in a random,coded order.The number of ICC per villus was compared among controls,Campylobacter recovered rats without small intestinal bacterial overgrowth(SIBO),and Campylobacter recovered rats with SIBO.RESULTS:Three months after recovery,27% of rats gavaged with C.jejuni had SIBO.The rats with SIBO had a lower number of DMP-ICC than controls in the jejunum and ileum.Additionally there appeared to be a density threshold of 0.12 DMP-ICC/villus that was associated with SIBO.If ileal density of DMP-ICC was < 0.12 ICC/villus,54% of rats had SIBO compared to 9% among ileal sections with > 0.12(P<0.05).If the density of ICC was < 0.12 DMP-ICC/villus in more than one location of the bowel,88% of these had SIBO compared to 6% in those who did not(P<0.001).CONCLUSION:In this post-infectious rat model,the development of SIBO appears to be associated with a reduction in DMP-ICC.Further study of this rat model might help understand the pathophysiology of postinfectious irritable bowel syndrome.Sam-Ryong Jee Walter Morales Kimberly Low Christopher Chang Amy Zhu Venkata Pokkunuri Soumya Chatterjee Edy Soffer Jeffrey L Conklin Mark Pimentel 2010World Journal of Gastroenterology2010,16,29:3
3QT prolongation is associated with increased mortality in end stage liver disease显示文摘AIM To determine the prevalence of QT prolongation in a large series of end stage liver disease(ESLD) patients and its association to clinical variables and mortality.METHODS The QT interval was measured and corrected for heart rate for each patient,with a prolonged QT cutoff defined as QT > 450 ms for males and QT > 470 ms for females.Multiple clinical variables were evaluated including sex,age,serum sodium,international normalized ratio,creatinine,total bilirubin,beta-blocker use,Model for EndStage Liver Disease(MELD),MELD-Na,and etiology of liver disease. RESULTS Among 406 ESLD patients analyzed,207(51.0%) had QT prolongation. The only clinical variable associated with QT prolongation was male gender(OR = 3.04,95%CI:2.01-4.60,P < 0.001). During the study period,187patients(46.1%) died. QT prolongation was a significant independent predictor of mortality(OR = 1.69,95%CI:1.03-2.77,P = 0.039). In addition,mortality was also associated with viral etiology of ESLD,elevated MELD score and its components(P < 0.05 for all). No significant reversibility in the QT interval was seen after liver transplantation. CONCLUSION QT prolongation was commonly encountered in an ESLD population,especially in males,and served as a strong independent marker for increased mortality in ESLD patients.Sun Moon Kim Bennet George Diego Alcivar-Franco Charles L Campbell Richard Charnigo Brian Delisle Jonathan Hundley Yousef Darrat Gustavo Morales Samy-Claude Elayi Alison L Bailey 2017World Journal of Cardiology2017,9,4:3
4Hepatitis C eradication with sofosbuvir leads to significant metabolic changes显示文摘AIM To assess the effect of sofosbuvir(SOF) based regimens on glycemic and lipid control.METHODS This is a retrospective analysis of hepatitis C virus(HCV)-infected patients treated and cured with a SOF regimen [SOF/ribavirin/interferon, SOF/simeprevir, or SOF/ledipasvir(LDV) ± ribavirin] from January 2014 to March 2015. Patients with hemoglobin A1C(HbA1C) and lipid panels within six months before and six months after therapy were identified and included in our study. Due to the known hemolytic effect of ribavirin, HbA1C was obtained a minimum of three months post-treatment for the patients treated with a ribavirin regimen. Medical history, demographics, HCV genotype, pre-therapy RNA, and liver biopsies were included in our analysis. The patients who started a new medication or had an adjustment of baseline medical management for hyper-lipidemia or diabetes mellitus(DM) were excluded from our analysis.RESULTS Two hundred and thirty-four patients were reviewed, of which 60 patients met inclusion criteria. Sixty-three point three percent were male, 26.7% were Caucasian, 41.7% were African American and 91.7% were infected with hepatitis C genotype 1. Mean age was 60.6 ± 6.7 years. Thirty-nine patients had HbA1C checked before and after treatment, of which 22 had the diagnosis of DM type 2. HbA1C significantly decreased with treatment of HCV(pretreatment 6.66% ± 0.95% vs posttreatment 6.14% ± 0.65%, P < 0.005). Those treated with SOF/LDV had a lower HbA1C response than those treated with other regimens(0.26% ± 0.53% vs 0.71% ± 0.83%, P = 0.070). Fifty-two patients had pre- and post-treatment lipid panels; there was a significant increase in low-density lipoprotein(LDL) and total cholesterol(TC) after treatment(LDL: 99.5 ± 28.9 mg/dL vs 128.3 ± 34.9 mg/dL, P < 0.001; TC: 171.6 ± 32.5 mg/dL vs 199.7 ± 40.0 mg/dL, P < 0.001). Pretreatment body-mass index(BMI) did not differ from post-treatment BMI(P = 0.684). CONCLUSION Eradication of HCV with a SOF regimen resulted in a significant drop in HbA1C and an increase in LDL and TC post therapy.Amilcar L Morales Zachary Junga Manish B Singla Maria Sjogren Dawn Torres 2016World Journal of Hepatology2016,8,35:2
5Hypervirial Theorem and Parameter differentiation: Closed Formulation for Harmonic Oscillator Integrals 显示文摘Morales J Lopez-Bonilla J L Palna A 1987Journal of Mathematical Physics1987,28,5:2
6Combinatorial optimization of group key management显示文摘M Eltoweissy M H Heydari L Morales 2004Jotlmal of Network and Systems Management: Special Issue on Network Security2004,12,1:1
7Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes 显示文摘Liu L Karkanias GB Morales JC 1998J Biol Chem1998,273,31:1
8Organoclays:Properties,preparation and applications显示文摘PATVA L B MORALES A R DIAZ F R V 2008Applied Clay Science2008,42,12:1
9Eelctrochemical treatment applied to food-processing industrial wastewatcr显示文摘D(I)AZ C B MORALES G R C(O)RDOBA L (A) 2006Industrial & Engineering Chemistry Research2006,45,:1
10Arginine vasopressin in the treatment of 50 patients with txstcardiotomy va- sodilatory shock显示文摘Morales D L S Gregg D Helman D N 2000Ann Thorac Surg2000,69,1:1
11Combinatorial optimization of key management in group eommunieations显示文摘Eltoweisy M Heydari H Morales L 2004Journal ol Network and Systems Management2004,12,1:1
12A connection between orthogonal polynomials on the unit circle and matrix orthogonal polynomials on the real line显示文摘M J Cantero M P Ferrer L Moral L Velazquez 2003Journal of Computational and Applied Mathematics2003,154,2:1
13Asymmetric reduction of aromatic ketones显示文摘Morales H R Perez-Juarez M Cuellar L 1984Synth Commun1984,14,13:1
14Plasticity of hippocampus following perinatal asphyxia: effects on postnatal apoptosis and neurogenesis 显示文摘MORALES P FIEDLER J L ANDRES S 2008J Neurosci Res2008,86,12:1
15Breast cancer and DNA repair capacity: association with use of nmhivitamin and calcium supplements 显示文摘Vergne Y Matta J Morales L 2013Integr Med (Encinitas)2013,12,3:1
16HPAEC-PAD oligosaccharide analysis to detect adulterations of honey with sugar syrups 显示文摘Morales V Corzo N Sanz M L 2008Food Chemistry2008,107,:1
17al,Regression of uterine leiomyomata in response to the anti-progesterone RU486显示文摘MURPHY A A KETTEL L M MORALES A J et 1993J Clin Endoerinol Metab1993,76,:1
18显示文摘Morales L Allub R Alascio B 2005Phys Rev B2005,72,13:1
19Expression of growth hormone secretagogue receptor type la, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors 显示文摘Gaytan F Morales C Barreiro M L 2005J Clin Endocrinol Metab2005,90,3:1
20Probabilistic power flow with correlated wind sources显示文摘Morales J M Baringo L ConejoAJ 2009IET Generation Transmission and Distribution2009,4,5:1
返回顶部 每页显示:
共42页 首页 上一页 第1页 下一页 末页 /42 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费